Recruiting

Let's Discuss Health

Sponsor:

Ciusss de L'Est de l'Île de Montréal

Code:

NCT05787145

Conditions

Prostatic Neoplasms

Psychological Distress

Physician-Patient Relations

Communication

Patient Participation

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Let's Discuss Health Group

Study Details

Brief summary:

In Canada, the prevalence of cancer is growing and contributes significantly to health costs. The prevention and treatment of cancer is a major concern of our health system. Many men with prostate cancer develop psychological distress. The emotional consequences of a cancer diagnosis and its treatments can prevent patients from communicating effectively with their healthcare team. It is recognized that the quality of communication between cancer patients and their caregivers plays an important role in the management of their disease. However, few tools are being developed to help clinicians and patients better communicate and decrease patients' psychological distress. Let's Discuss Health (www.discutonssante.ca) is a French-language website that offers several tools to support collaboration between caregivers and cancer patients.

The objectives of this research project are to assess the experience of using the Let's Discuss Health website and the impact of its use on the quality of communication between radiation oncologists and patients, the level of distress of patients with prostate cancer, recall of the information discussed as well as adherence to the trajectory in radiation oncology.

The project will take place in three radiation oncology centers in Quebec. Two groups of prostate cancer patients will be recruited. Patients in the first group will be assessed on the basis of regular consultations and those in the second group will be encouraged to prepare for their medical visits using the Let's Discuss Health website. Patients and their caregivers will answer short questionnaires before and after four targeted consultations (initial visit, mid-treatment visit, end-of-treatment visit and 3-month post-treatment visit). Focus groups will also be organized to explore the impact of the website.

This project offers the potential to transform clinical practices in radiation oncology to reduce the burden of cancer and improve the quality of care offered to patients with cancer.

Conditions

Prostatic Neoplasms

Psychological Distress

Physician-Patient Relations

Communication

Patient Participation

Study ID

NCT05787145

Start date

Mar 10, 2021

Status verified date

Mar, 2023

Completion date

Nov, 2024

Anticipated

Primary completion date

Nov, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • have a diagnosis of prostate cancer
  • understand, speak and read French
  • report being comfortable using the Internet
  • have access to a computer, tablet or smartphone or know someone who does and is willing to accompany them

Exclusion Criteria:

  • being considered unfit to give free and informed consent (e.g. dementia, severe psychiatric condition)
  • any other clinical reason (poor health of the patient at the time of the consultation) that the clinician deems relevant

Study Design

Enrollment

300 participants

Anticipated

Allocation

Non randomized

Intervention Model

Sequential

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Let's Discuss Health Group

Patients in this group will be encouraged to prepare each of the four medical encounters targeted in the trajectory in radiation oncology using Let's Discuss Health website, which are the initial visit, the mid-treatment visit, the end-of-treatment visit and the 3-month post-treatment visit.

no intervention: Usual Care Group

Patients in this group will received the usual care in the radiation oncology care pathway.

Interventions

Let's Discuss Health Group

Use of the Let's Discuss Health website to prepare four medical encounters with the radiation oncologist throughout the radiation care trajectory.

Primary outcome measure

  • Patient use of Let's Discuss Health tools [ Time Frame: Through study completion, an average of 8 months ]
  • Dialogic rate in the exchanges during the initial patient-radiation oncologist encounter [ Time Frame: Baseline (0 week) ]
  • Dialogic rate of the conversations during the end-of-treatment patient-radiation oncologist encounter [ Time Frame: Up to 5 months ]
  • Pre-consultation patient emotional distress during the care trajectory [ Time Frame: Through study completion, an average of 8 months ]
  • Patient recall of information after the initial encounter [ Time Frame: Baseline (0 week) ]
  • Patient recall of information after the end-of-treatment encounter [ Time Frame: Up to 5 months ]
  • Adherence to the care pathway [ Time Frame: Through care pathway completion, an average of 5 weeks ]

Central Contacts and Locations

Central contacts

Marie-Thérèse Lussier, MD, MSc

514-966-4615marie.therese.lussier@umontreal.ca

Marie-Eve Lavoie, PhD

514-966-4615marie.eve.lavoie.cissslav@ssss.gouv.qc.ca

Locations

Centre intégré de cancérologie de Laval

Recruiting

Laval, Quebec, Canada, H7M 3L9

Contacts

Marie-Eve Lavoie, PhD

514-966-4615marie.eve.lavoie.cissslav@ssss.gouv.qc.ca

Principal Investigator:

Marie-Andrée Fortin, MD

Ciusss de l'Est de l'Île de Montréal

Recruiting

Montréal, Quebec, Canada

Contacts

Marie-Eve Lavoie, PhD

514-966-4615marie.eve.lavoie.cissslav@ssss.gouv.qc.ca

Principal Investigator:

Israël Fortin, MD

Centre hospitalier universitaire de Québec

Recruiting

Québec, Canada

Contacts

Marie-Eve Lavoie, PhD

514-966-4615marie.eve.lavoie.cissslav@ssss.gouv.qc.ca

Principal Investigator:

William Foster, MD

More Information

Sponsor

Ciusss de L'Est de l'Île de Montréal

Last update posted

Mar 28, 2023

Last verified

Mar, 2023

Keywords

  • Prostate Cancer
  • Patient-Physician Communication
  • Patient Recall of Information
  • Adult

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ciusss de L'Est de l'Île de Montréal on 2023-03-28.